Reuters Events Pharmarevenue
Other AgencyLondon, England, United KingdomFounded 2002CEO Blair Gottscho
Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry.
Reuters Events Pharma revenue
Reuters Events Pharma has not published its revenue. GetLatka estimates it at about $2.7M a year (October 2024).
| As of | Revenue | Source |
|---|---|---|
| Apr 2021 | $2M | – |
| Dec 2023 | $1.6MEST. | GetLatka estimate |
| Oct 2024 | $2.7MEST. | GetLatka estimate |
– source not recorded
Reuters Events Pharma CEO, founders & employees
Blair Gottscho founded Reuters Events Pharma in 2002 and runs it as CEO. Reuters Events Pharma has 16 employees (October 2024, LinkedIn).
- Blair GottschoCo-founder & CEO
All 3 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Oct 2024 | 16 | |
| Dec 2023 | 16 | |
| Apr 2021 | 24 | – |
Reuters Events Pharma FAQ
How much money does Reuters Events Pharma make?
Reuters Events Pharma has not published its revenue. GetLatka estimates about $2.7M a year (October 2024).
Who is the CEO of Reuters Events Pharma?
Blair Gottscho, a co-founder.
Who founded Reuters Events Pharma?
Blair Gottscho, in 2002.
How many employees does Reuters Events Pharma have?
About 16 as of October 2024 (LinkedIn).
Browse Other Agency
- Org 3D$2.7M
- OnTarget CPA$2.7M
- My Single Point$2.7M
- EasyCloud Consultants Pvt Ltd$2.7M
- Terrapin Technologies$2.7M
- Gurulize$2.7M
- feature[23]$2.7M
- MonkeyPatch.io$2.7M
- Boomtime$2.7M
- Socialproof$2.7M
- Whipcord$2.7M
- Functionly$2.7M
- Galactica$2.7M
- PSFK$2.7M
- Dks Systems$2.7M
- Aurelia Ventures$2.7M
- Nessis$2.7M
- Red Butler$2.7M
- Local Hero GmbH$2.7M
How this page is sourced
2 from public sources · 2 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST. and say whose they are. Not financial advice.
Updated Oct 17, 2024Data disclaimerReport a correctionClaim this profileRun Reuters Events Pharma? Join the podcast